Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice. [electronic resource]
- Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 12 2016
- 703-707 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1534-4436
10.1016/j.anai.2016.08.006 doi
Anti-Allergic Agents--therapeutic use Chronic Disease--drug therapy Humans Omalizumab--therapeutic use Urticaria--drug therapy